增强的CD46诱导调节性T细胞在尘螨特异性免疫治疗后抑制过敏性炎症。 - Suppr | 超能文献

相似文献

1

Enhanced CD46-induced regulatory T cells suppress allergic inflammation after Dermatophagoides pteronyssinus-specific immunotherapy.增强的CD46诱导调节性T细胞在尘螨特异性免疫治疗后抑制过敏性炎症。

J Allergy Clin Immunol. 2014 Nov;134(5):1206-9.e1. doi: 10.1016/j.jaci.2014.06.005. Epub 2014 Jul 25.

2

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.在一项双盲、安慰剂对照研究中，用改良的屋尘螨和粉尘螨提取物成功治疗螨过敏性哮喘。

J Allergy Clin Immunol. 2006 Nov;118(5):1026-32. doi: 10.1016/j.jaci.2006.07.043. Epub 2006 Sep 18.

3

Safety of specific immunotherapy using a depigmented and polymerised extract of Dermatophagoides pteronyssinus in children under five years of age.使用变应原提取物的特异性免疫疗法在五岁以下儿童中的安全性：以屋尘螨变应原提取物为例

Allergol Immunopathol (Madr). 2011 Sep-Oct;39(5):267-70. doi: 10.1016/j.aller.2010.09.002. Epub 2011 Feb 18.

4

Long-term efficacy of allergen immunotherapy: what do we expect?变应原免疫治疗的长期疗效：我们有何期待？

Immunotherapy. 2013 Feb;5(2):131-3. doi: 10.2217/imt.12.154.

5

Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.

Allergol Immunopathol (Madr). 2013 Jan-Feb;41(1):1-3. doi: 10.1016/j.aller.2012.12.001. Epub 2013 Jan 10.

6

The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.口服类固醇联合或不联合维生素 D3 对哮喘儿童免疫治疗早期疗效的影响。

Clin Exp Allergy. 2009 Dec;39(12):1830-41. doi: 10.1111/j.1365-2222.2009.03357.x. Epub 2009 Oct 7.

7

Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.尘螨变应原特异性免疫疗法对哮喘儿童血清白细胞介素-13及肺功能的影响

Chin Med J (Engl). 2009 May 20;122(10):1157-61.

8

Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.屋尘螨集群免疫疗法与传统免疫疗法方案的双盲对照研究。

J Allergy Clin Immunol. 2005 Jul;116(1):109-18. doi: 10.1016/j.jaci.2005.05.005.

9

Th17 response to Dermatophagoides pteronyssinus is related to late-phase airway and systemic inflammation in allergic asthma.Th17 对尘螨的反应与过敏性哮喘的晚期气道和全身炎症有关。

Int Immunopharmacol. 2013 Dec;17(4):1020-7. doi: 10.1016/j.intimp.2013.10.004. Epub 2013 Oct 22.

10

Subcutaneous allergen immunotherapy may be a suitable treatment for exacerbator allergic asthma.皮下过敏原免疫疗法可能是治疗加重型过敏性哮喘的一种合适疗法。

Ann Allergy Asthma Immunol. 2018 Aug;121(2):258-259. doi: 10.1016/j.anai.2018.05.021. Epub 2018 May 25.

引用本文的文献

1

A Novel Computational Framework for Predicting the Survival of Cancer Patients With PD-1/PD-L1 Checkpoint Blockade Therapy.一种用于预测接受PD-1/PD-L1检查点阻断疗法的癌症患者生存情况的新型计算框架。

Front Oncol. 2022 Jun 27;12:930589. doi: 10.3389/fonc.2022.930589. eCollection 2022.

2

Lupus nephritis with corticosteroid responsiveness: molecular changes of CD46-mediated type 1 regulatory T cells.狼疮性肾炎伴糖皮质激素反应性：CD46 介导的 1 型调节性 T 细胞的分子变化。

Pediatr Res. 2022 Oct;92(4):1099-1107. doi: 10.1038/s41390-021-01882-z. Epub 2021 Dec 24.

3

[Allergic immunotherapy in children and adolescents].